[1]
2025. REDEFINING ALZHEIMER’S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS. Journal of Medical & Health Sciences Review. 2, 4 (Dec. 2025). DOI:https://doi.org/10.65035/w1y9ey43.